Equities

Thyrocare Technologies Ltd

THYROCARE:NSI

Thyrocare Technologies Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)976.55
  • Today's Change35.55 / 3.78%
  • Shares traded140.54k
  • 1 Year change+80.18%
  • Beta0.5096
Data delayed at least 15 minutes, as of Nov 14 2024 10:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1,4611,4011,388
Total Receivables, Net468894953
Total Inventory523302344
Prepaid expenses272612
Other current assets, total3061072.80
Total current assets2,7852,7292,700
Property, plant & equipment, net2,0371,9441,868
Goodwill, net1,0401,0031,003
Intangibles, net6.907.908.30
Long term investments256221209
Note receivable - long term29425.20
Other long term assets--016
Total assets6,4396,3276,077
LIABILITIES
Accounts payable401240165
Accrued expenses121055
Notes payable/short-term debt10700
Current portion long-term debt/capital leases897250
Other current liabilities, total295449375
Total current liabilities905771645
Total long term debt227161157
Total debt423233207
Deferred income tax09.806.00
Minority interest8.609.200
Other liabilities, total31332.70
Total liabilities1,171984811
SHAREHOLDERS EQUITY
Common stock530529529
Additional paid-in capital743727715
Retained earnings (accumulated deficit)3,6103,8533,987
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total342189--
Total equity5,2685,3435,266
Total liabilities & shareholders' equity6,4396,3276,077
Total common shares outstanding535353
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.